ANALYSIS: Questions over Abano's Australian operations as sales slump continues

ANALYSIS: Questions over Abano's Australian operations as sales slump continues
Jenny Ruth
By Jenny Ruth July 31 (BusinessDesk) - Abano Healthcare continues to do it tough in Australia where, even though it’s the second-largest corporate player, it has less than 2 percent of the market. Its annual sales across the Tasman haven’t grown since 2012 and appear to be getting worse; a 1.6 percent fall in same-store sales in the nine months ended February turned into a 2.9 percent decline for the year ended May. Abano has acknowledged some of that rot is permanent because it wrote off $2.6 million in goodwill relating to four of it...

More Opinion

FNZ and the global chase for scale
Opinion

David Chaplin: FNZ and the global chase for scale

Will FNZ list as the biggest investment platform of the mid-21st century?

New Zealand's great white hope
Opinion

Dileepa Fonseka: New Zealand's great white hope

The primary sector can't be expected to carry the whole country.

Dileepa Fonseka 09 Jun 2025
A roadmap for global investment
Opinion

Simon Robertson: A roadmap for global investment

The drawdowns and the snapbacks in the markets have been brutal.

Simon Robertson 07 Jun 2025
Turf war: Sheep vs forestry
Opinion

Richard Holloway: Turf war: Sheep vs forestry

Rather than vilifying forestry, Federated Farmers should focus on the facts.

Richard Holloway 06 Jun 2025